Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.

As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition...

Full description

Bibliographic Details
Main Authors: Mun Chiang Chan, Onur Atasoylu, Emma Hodson, Anthony Tumber, Ivanhoe K H Leung, Rasheduzzaman Chowdhury, Verónica Gómez-Pérez, Marina Demetriades, Anna M Rydzik, James Holt-Martyn, Ya-Min Tian, Tammie Bishop, Timothy D W Claridge, Akane Kawamura, Christopher W Pugh, Peter J Ratcliffe, Christopher J Schofield
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4492579?pdf=render
_version_ 1818533448138096640
author Mun Chiang Chan
Onur Atasoylu
Emma Hodson
Anthony Tumber
Ivanhoe K H Leung
Rasheduzzaman Chowdhury
Verónica Gómez-Pérez
Marina Demetriades
Anna M Rydzik
James Holt-Martyn
Ya-Min Tian
Tammie Bishop
Timothy D W Claridge
Akane Kawamura
Christopher W Pugh
Peter J Ratcliffe
Christopher J Schofield
author_facet Mun Chiang Chan
Onur Atasoylu
Emma Hodson
Anthony Tumber
Ivanhoe K H Leung
Rasheduzzaman Chowdhury
Verónica Gómez-Pérez
Marina Demetriades
Anna M Rydzik
James Holt-Martyn
Ya-Min Tian
Tammie Bishop
Timothy D W Claridge
Akane Kawamura
Christopher W Pugh
Peter J Ratcliffe
Christopher J Schofield
author_sort Mun Chiang Chan
collection DOAJ
description As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs). Here, we report studies on tricyclic triazole-containing compounds as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate. One compound (IOX4) induces HIFα in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.
first_indexed 2024-12-11T17:58:49Z
format Article
id doaj.art-270e114bd2074970b400b2da1562426e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T17:58:49Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-270e114bd2074970b400b2da1562426e2022-12-22T00:55:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013200410.1371/journal.pone.0132004Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.Mun Chiang ChanOnur AtasoyluEmma HodsonAnthony TumberIvanhoe K H LeungRasheduzzaman ChowdhuryVerónica Gómez-PérezMarina DemetriadesAnna M RydzikJames Holt-MartynYa-Min TianTammie BishopTimothy D W ClaridgeAkane KawamuraChristopher W PughPeter J RatcliffeChristopher J SchofieldAs part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs). Here, we report studies on tricyclic triazole-containing compounds as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate. One compound (IOX4) induces HIFα in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.http://europepmc.org/articles/PMC4492579?pdf=render
spellingShingle Mun Chiang Chan
Onur Atasoylu
Emma Hodson
Anthony Tumber
Ivanhoe K H Leung
Rasheduzzaman Chowdhury
Verónica Gómez-Pérez
Marina Demetriades
Anna M Rydzik
James Holt-Martyn
Ya-Min Tian
Tammie Bishop
Timothy D W Claridge
Akane Kawamura
Christopher W Pugh
Peter J Ratcliffe
Christopher J Schofield
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
PLoS ONE
title Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
title_full Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
title_fullStr Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
title_full_unstemmed Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
title_short Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
title_sort potent and selective triazole based inhibitors of the hypoxia inducible factor prolyl hydroxylases with activity in the murine brain
url http://europepmc.org/articles/PMC4492579?pdf=render
work_keys_str_mv AT munchiangchan potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT onuratasoylu potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT emmahodson potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT anthonytumber potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT ivanhoekhleung potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT rasheduzzamanchowdhury potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT veronicagomezperez potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT marinademetriades potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT annamrydzik potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT jamesholtmartyn potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT yamintian potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT tammiebishop potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT timothydwclaridge potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT akanekawamura potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT christopherwpugh potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT peterjratcliffe potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain
AT christopherjschofield potentandselectivetriazolebasedinhibitorsofthehypoxiainduciblefactorprolylhydroxylaseswithactivityinthemurinebrain